AABB is the leader in setting standards that optimize and advance quality and safety for the blood and biotherapies field.
Since 1957, AABB standards have been the backbone of AABB’s mission. AABB standards are currently applied to AABB-Accredited facilities in more than 50 countries and other facilities to advance their quality and safety measures.
View and Purchase Current Standards
AABB Standards combine internationally accepted quality management system requirements with relevant technical requirements for each discipline. As such, the Standards can serve as the basis for accreditation anywhere in the world. AABB Standards are based on AABB’s Quality Systems Essentials which leads the field in quality standards worldwide.
AABB standards incorporate both technical and quality systems standards to ensure that all facets are reviewed - from specification of equipment, materials management, and organizational structure to documents, resource management, and program assessment.
Each edition of AABB's Standards is developed by a team of experts who volunteer their time as a member of a Standards Committee. Each edition of AABB's Standards is based on best medical practice, scientific data, principles associated with good manufacturing practices and quality assurance, and applicable regulations. Each revision cycle includes a public comment period that seeks input from active professionals throughout the world.
Seventh Edition of Molecular Testing Standards Takes Effect Jan. 1
December 18, 2024
December 09, 2024
AABB Accepting Feedback on Cell and Gene Therapy Standards for Pharmacy
November 19, 2024